Literature DB >> 29256602

Enhanced Targeted Gene Transduction: AAV2 Vectors Conjugated to Multiple Aptamers via Reducible Disulfide Linkages.

Yuan Wu1,2, Liqin Zhang1,2, Cheng Cui2, Sena Cansiz2, Hao Liang1, Cuichen Wu1,2, I-Ting Teng2, Weijun Chen1,3,2, Yuan Liu1,2, Weijia Hou2, Xiaobing Zhang1, Weihong Tan1,3,2.   

Abstract

Enhanced targeted gene transduction by AAV2 vectors is achieved by linking the vector to multiple sgc8 aptamers, which are selective for cell membrane protein PTK7. Aptamer molecules are conjugated to multiple sites on a DNA dendrimer (G-sgc8), which is then linked to AAV2 via a dithiobis(succinimidyl propionate) cross-linker containing a disulfide group, which can facilitate the release of AAV2 vectors by reaction with the reduced form of intracellular glutathione. The G-sgc8-AAV2 vectors showed a 21-fold enhancement in binding affinity and an enhanced ability to protect sgc8 aptamers against nuclease degradation to cells expressing PTK7 compared to single aptamer-AAV2 conjugates. The transduction efficiency was tested by loading AAV2 with the gene for green fluorescent protein. Therefore, this modified recombinant vector is an attractive and promising tool for targeted biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29256602      PMCID: PMC5877795          DOI: 10.1021/jacs.7b08518

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  18 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

Authors:  M A Kay; C S Manno; M V Ragni; P J Larson; L B Couto; A McClelland; B Glader; A J Chew; S J Tai; R W Herzog; V Arruda; F Johnson; C Scallan; E Skarsgard; A W Flake; K A High
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Template-directed covalent conjugation of DNA to native antibodies, transferrin and other metal-binding proteins.

Authors:  Christian B Rosen; Anne L B Kodal; Jesper S Nielsen; David H Schaffert; Carsten Scavenius; Anders H Okholm; Niels V Voigt; Jan J Enghild; Jørgen Kjems; Thomas Tørring; Kurt V Gothelf
Journal:  Nat Chem       Date:  2014-07-20       Impact factor: 24.427

4.  Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody.

Authors:  J S Bartlett; J Kleinschmidt; R C Boucher; R J Samulski
Journal:  Nat Biotechnol       Date:  1999-02       Impact factor: 54.908

Review 5.  Adeno-associated virus-mediated cancer gene therapy: current status.

Authors:  Jingfeng Luo; Yuxuan Luo; Jihong Sun; Yurong Zhou; Yajing Zhang; Xiaoming Yang
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

6.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 7.  Receptor targeting of adeno-associated virus vectors.

Authors:  H Büning; M U Ried; L Perabo; F M Gerner; N A Huttner; J Enssle; M Hallek
Journal:  Gene Ther       Date:  2003-07       Impact factor: 5.250

8.  Cell-specific internalization study of an aptamer from whole cell selection.

Authors:  Zeyu Xiao; Dihua Shangguan; Zehui Cao; Xiaohong Fang; Weihong Tan
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

9.  Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.

Authors:  M G Kaplitt; P Leone; R J Samulski; X Xiao; D W Pfaff; K L O'Malley; M J During
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

Review 10.  Multivalent polymers for drug delivery and imaging: the challenges of conjugation.

Authors:  Mallory A van Dongen; Casey A Dougherty; Mark M Banaszak Holl
Journal:  Biomacromolecules       Date:  2014-08-22       Impact factor: 6.988

View more
  5 in total

Review 1.  Aptamer-based targeted therapy.

Authors:  Guizhi Zhu; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-08-17       Impact factor: 15.470

2.  Aptamer-assisted tumor localization of bacteria for enhanced biotherapy.

Authors:  Zhongmin Geng; Zhenping Cao; Rui Liu; Ke Liu; Jinyao Liu; Weihong Tan
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

3.  Dynamic Continuum of Nanoscale Peptide Assemblies Facilitates Endocytosis and Endosomal Escape.

Authors:  Hongjian He; Jiaqi Guo; Jiashu Xu; Jiaqing Wang; Shuang Liu; Bing Xu
Journal:  Nano Lett       Date:  2021-05-03       Impact factor: 11.189

Review 4.  Oligonucleotide-Based Therapies for Renal Diseases.

Authors:  Fernando Cartón-García; Cassondra Jeanette Saande; Daniel Meraviglia-Crivelli; Rafael Aldabe; Fernando Pastor
Journal:  Biomedicines       Date:  2021-03-16

Review 5.  Multivalent Aptamer Approach: Designs, Strategies, and Applications.

Authors:  Zhong Wang; Xiuying Yang; Nicholas Zhou Lee; Xudong Cao
Journal:  Micromachines (Basel)       Date:  2022-03-12       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.